CoChat

Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes

Open access
Sio, Terence T., Lin, Huei-Kai, Shi, Qiuling, Gunn, G. Brandon, Cleeland, Charles S., Lee, J. Jack, Hernandez, Mike, Blanchard, Pierre, Thaker, Nikhil G., Phan, Jack, Rosenthal, David I., Garden, Adam S., Morrison, William H., Fuller, C. David, Mendoza, Tito R., Mohan, Radhe, Wang, Xin Shelley, Frank, Steven J. · 2016 · International Journal of Radiation Oncology*Biology*Physics
Cited by 166

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Purpose We hypothesized that patients with oropharyngeal cancer treated with intensity-modulated proton therapy (IMPT) would have lower symptom burdens, as measured by patient-reported outcome (PRO) surveys, than patients treated with intensity-modulated photon therapy (IMRT). Methods and Materials Patients were treated for oropharyngeal cancer from 2006 to 2015 through prospective registries with concurrent chemo-IMPT or chemo-IMRT and completed the MD Anderson Symptom Inventory-Head and Neck Cancer (MDASI-HN) module at various times before treatment (baseline), during treatment (acute), within the first 3 months after treatment (subacute), and afterward (chronic phases). Individual symptoms and the top 5 and top 11 most severe symptoms were summarized and compared between the radiotherapy modalities. Results PRO data were collected and analyzed from 35 patients treated with chemo-IMPT and 46 treated with chemo-IMRT. Baseline symptom burdens were similar between both groups. The overall top 5 symptoms were food taste problems (mean score 4.91 [on a 0–10 scale]), dry mouth (4.49), swallowing/chewing difficulties (4.26), lack of appetite (4.08), and fatigue (4.00). Among the top 11 symptoms, changes in taste and appetite during the subacute and chronic phases favored IMPT (all P<0.048). No differences in symptom burden were detected between modalities during the acute and chronic phases by top-11 symptom scoring. During the subacute phase, the mean (±SD) top 5 MDASI scores were 5.15 ± 2.66 for IMPT vs. 6.58 ± 1.98 for IMRT (P=0.013). Conclusions Using the MDASI-HN, symptom burden was reduced in the IMPT patients during the subacute recovery phase following treatment. A prospective randomized clinical trial is underway to define the value of IMPT in the management of head and neck tumors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijrobp.2016.02.044

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Metadata

Authors
Sio, T. T., Lin, H.-K., Shi, Q., Gunn, G. B., Cleeland, C. S., Lee, J. J., Hernandez, M., Blanchard, P., Thaker, N. G., Phan, J., Rosenthal, D. I., Garden, A. S., Morrison, W. H., Fuller, C. D., Mendoza, T. R., Mohan, R., Wang, X. S., & Frank, S. J.
Venue
International Journal of Radiation Oncology*Biology*Physics
Publisher
Elsevier BV
Published
2016-07
Volume
95
Issue
4
Pages
1107-1114
ISSN
0360-3016 (ISSN-L)
OpenAlex
W2276874817
Cited by
166
References
25
FWCI
11.65
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.